Dietary Supplements Market Analysis

  • Report ID: 6075
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Dietary Supplements Market Analysis

Type (Vitamins & Minerals, Botanicals, Proteins & Amino Acids, Fatty-Acids, Prebiotics & Probiotics)

Proteins & amino acids segment is set to dominate around 38% dietary supplements market share by the end of 2037. Many countries are experiencing an increase in vitamin deficiencies, thus people are turning to vitamin supplements to make up for this. As per the data provided by WHO, it is believed that over 2 billion individuals worldwide suffer from deficiencies in important vitamins and minerals, specifically iron, zinc, iodine, and vitamin A.

The demand for minerals is increasing because deficiency in these elements can cause serious health problems in both adults and expectant mothers. In the next years, there will likely be a rise in bodybuilding and weight loss activities, which will drive up demand for protein supplements. The for herbal dietary supplements market has shown substantial value sales growth, with botanicals coming in second.

Growing consumer awareness of the health benefits of eating plant-based foods and a rise in health-conscious consumers are the main factors driving the market for herbal supplements. Some of the main herbal dietary supplements that have become increasingly well-known recently are cranberries, horehound, yohimbe, black cohosh, senna, cinnamon, and flaxseed.

Form (Tablets, Capsules, Powders, Gummies, Softgels, Liquids)

Softgels segment in the dietary supplements market is set to showcase lucrative growth rate through 2037. The segment growth can be credited to compared to pills and hard capsules, soft gels offer a number of benefits and appealing characteristics. Because soft gelatin capsules are easy to swallow and quickly dissolve, it is estimated that they will greatly accelerate the rate at which active ingredients are absorbed. Furthermore, it is estimated that these capsules are customized for specific uses. Another benefit of soft gels is their extraordinary versatility. A vast range of shell colors, shapes, and sizes are available to help products stand out in the marketplace.

The cost-effectiveness and simple packaging of soft gel supplements are other factors contributing to their rising popularity. Their benefit is that they have exactly specified dosages, which liquid or other forms do not have. Because of this distinction, soft gel supplements are now more widely used than liquid ones. For instance, the US-based multinational company Catalent Inc. announced the release of Optigel DR softgel capsules in October 2020. Pectin is used in the formation of the medications, which are made with OptiGel DR technology.

Our in-depth analysis of the dietary supplements market includes the following segments:

          Type

  • Vitamins & Minerals
  • Botanicals
  • Proteins & Amino Acids
  • Fatty-Acids
  • Prebiotics & Probiotics

          Form

  • Tablets
  • Capsules
  • Powders
  • Gummies
  • Softgels
  • Liquids

          Health Applications

  • General Health
  • Bone & Joint Health
  • Energy & Weight Management
  • Gastrointestinal Health
  • Immunity
  • Cardiac Health
  • Diabetes
  • Brain/Mental Health
  • Skin/Hair/Nails

 

          Distribution Channels

 

  • Pharmacies & Drug Stores
  • Supermarkets/Hypermarkets
  • Online Retail

          End User

  • Children
  • Women
  • Men
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Parul Atri


  • Report ID: 6075
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of dietary supplements is assessed at USD 199.47 billion.

The dietary supplements market size was over USD 186.49 billion in 2024 and is projected to reach USD 551.62 billion by 2037, witnessing around 8.7% CAGR during the forecast period i.e., between 2025-2037. A growing aging population and rising consumer health consciousness will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, influenced by prevalence of both chronic and non-chronic ailments in the region.

The major players in the market are Pfizer Inc, Bayer AG, Glanbia PLC, Abbott, Archer Daniels Midland Company, Herbalife International of America, Inc., GlaxoSmithKline plc, Himalaya Global Holdings Ltd., Amway Corporation, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample